Vijaya Diagnostic Centre Ltd (VIJAYA) is currently trading at 1,548.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Vijaya Diagnostic Centre is a leading integrated B2C diagnostic chain in India offering pathology and radiology services across an expanding hub-and-spoke network; founded in 1981, it operates 162 centres across 27 cities with NABL/NABH accreditations and advanced imaging capabilities including PET-CT, 3T MRI and automated labs. The company delivered a robust Q3 FY26: revenue of INR 2,052 million, EBITDA INR 861 million (41.9% margin) and PAT INR 432 million (21.0% margin), with volume-led growth (tests +14.7% YoY) and improvements in revenue per test and per footfall, indicating strong unit economics. Vijaya remains highly B2C focused (92% of revenue) and geographically concentrated—Hyderabad contributes ~68–69% of revenue—while actively diversifying via rapid hub deployments in West Bengal, Pune and Bengaluru and by integrating acquired PH and Medinova assets into the Vijaya brand. Operationally the company shows faster-than-expected ramp-ups: several newly launched hubs in non-core geographies (e.g., Krishnanagar, Barasat) reached break-even within about three quarters, demonstrating demand pull and effective local execution for Vijaya Diagnostic Centre’s hub model. Financially well positioned with surplus cash (~INR 260 crore at 31-Dec-25), consistent cash generation and guidance for FY27 capex of INR 100–120 crore, Vijaya Diagnostic Centre is balancing growth capex, digital/IT investments and targeted hiring to support the next leg of network expansion.

Over the past 52 weeks, Vijaya Diagnostic Centre Ltd has traded between a low of ₹847.90 and a high of ₹1,576.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Vijaya Diagnostic Centre Ltd has a market capitalization of approximately 16,041.89. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Vijaya Diagnostic Centre Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 85.56 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 16,041.89 Cr, Vijaya Diagnostic Centre Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Vijaya Diagnostic Centre Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Vijaya Diagnostic Centre Ltd is 85.56. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Consolidated total income was ₹239.5122 crore and consolidated profit after tax was ₹53.1011 crore for the quarter ended June 30, 2026.

The IPO opened on September 1, 2021 and closed on September 3, 2021.